Lactobacillus fermentum SRK414 | 6 mon randomized, double-blind, placebo-controlled trial | ↑ Femur, neck bone mineral density (BMD); maintenance of osteocalcin (OC) levels, indicating improved bone turnover | Han et al. (2022) |
Bacillus subtilis C-3102 | 6 mon randomized, placebo-controlled, double-blind clinical trial | ↑ Hip BMD, ↓ urinary type I collagen cross-linked N-telopeptide (uNTx), ↓ tartrate-resistant acid phosphatase isoform 5b (TRACP-5b), modulation of gut microbiota | Takimoto et al. (2018) |
Lactobacillus reuteri ATCCPTA 6475 | 12 mon randomized, placebo-controlled, double-blind clinical trial | ↓ Loss of tibia volumetric BMD; protective effects on bone microarchitecture | Nilsson et al. (2018) |
Lactobacillus casei, Bifidobacterium longum, Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus bulgaricus, Bifidobacterium breve, Streptococcus thermophilus | 6 mon randomized, double-blind, placebo-controlled clinical trial | ↓ Bone turnover markers (BALP, CTX) and pro-inflammatory cytokine; slowed bone turnover, beneficial for osteopenic postmenopausal women | Jafarnejad et al. (2017) |
Proprietary lactic acid bacteria culture in red clover extract (RLE) | 12 mon double-blind, placebo-controlled randomized trial | ↓ BMD loss in lumbar spine, femoral neck, and trochanter; ↓ CTX; improved estrogen metabolism | Lambert et al. (2017) |
L. reuteri NCIMB 30242 | 13 wk double-blind, placebo-controlled, randomized trial | ↑ Serum 25-hydroxyvitamin D levels by 25.5% | Jones et al. (2013) |
Lactobacillus helveticus LBK-16H (fermented milk) | 1 mon randomized, double-blind, crossover clinical study | ↓ Serum parathyroid hormone levels↑ Serum calcium concentrations | Narva et al. (2004b) |